Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Lynx signs two agreements with BASF

Nov. 1, 1996

Strategy and outlook for HemaSure's blood pathogen inactivation system

Nov. 1, 1996

Andrx drug delivery technology receives patent coverage

Nov. 1, 1996

Varian, Stanford University and SRI collaborative agreement aimed at new cancer cures

Nov. 1, 1996

3-Dimensional Pharmaceutical's DirectedDiversity technology for drug discovery

Nov. 1, 1996

Xenova, Warner-Lambert sign drug discovery collaborative agreement

Nov. 1, 1996

NIH seeks licensees for method of detecting cardiac electrical activity

Oct. 25, 1996

Five SBIR grants awarded to GeneMedicine

Oct. 25, 1996

KS Biomedix-Roche antibody collaboration

Oct. 25, 1996

Medarex receives federal funding for Bispecific technology

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...